CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
to evaluate zimberelimab (AB122) combined with domvanalimab (AB154) in front-line, PD-L1-high, locally advanced or metastatic Non-Small Cell Lung...
Phase 2
Houston, Texas, United States and 107 other locations
This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...
Phase 2
Houston, Texas, United States and 83 other locations
chemotherapy (carboplatin and pemetrexed) in people with metastatic lung cancer that has a change (mutation) in the gene EGFR. Osim ...
Phase 2
Houston, Texas, United States and 17 other locations
and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...
Phase 2
Kingwood, Texas, United States and 47 other locations
Study of MGY825 single agent in adult patients with advanced non-small cell lung cancer....
Phase 1
Houston, Texas, United States and 13 other locations
The primary objective of this study is to evaluate the safety and tolerability of subcutaneous (SC) tarlatamab.
Phase 1
Houston, Texas, United States and 24 other locations
of carboplatin and paclitaxel) and radiation in patients with lung cancer.You are being asked to take part in this study because yo ...
Phase 2
Houston, Texas, United States
This is a Phase 2, multi-center, open-label study to evaluate the safety and efficacy of VGT-309, a tumor-targeted, activatable fluorescent ...
Phase 2
Houston, Texas, United States and 5 other locations
Chimeric Degradation Activation Compound (CDAC). BG-60366 is designed to degrade mutant EGFR, which is a common cause for Non-Small Cell Lung...
Phase 1
Houston, Texas, United States and 38 other locations
the safety and tolerability of itacitinib in combination with osimertinib in subjects with locally advanced or metastatic non-small cell lung...
Phase 1, Phase 2
Houston, Texas, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal